MENU
CLNN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Clene (CLNN) Ownership - Who owns Clene?
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics... Show more
Profile
Industry
N/A
Address
6550 South Millrock Drive
Phone
+1 801 676-9695
Employees
85
Web
https://www.clene.com
Details
Group
Domestic Stock Funds
Category
Consumer Non Durables
Capitalization
38.88M
P/E Ratio
N/A
Total Cash
9.83M
Projected Growth
N/A
Total Debt
20.94M
Revenue
350K
Risk (Beta)
0.14
Dividend Yield
N/A
Total Cash/Share
1.09
Total Debt/Equity
N/A
Revenue/Share
0.05 USD as % of share price
Fundamentals
CLNN
Capitalization
38.9M
P/E Ratio
N/A
Risk (Beta)
0.14
Dividend Yield
N/A
Total Cash
9.83M
Total Cash/Share
1.09
Total Debt
20.9M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.05%
Revenue
350K
ROE
N/A
Book Value
-4.97M
P/B Ratio
9.03
Cash Flow
N/A
Earnings
-4.03
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1K
Current Ratio
1.36
Current Revenue Per Employee
1065.79
Dividends Per Share - Security
N/A
EBITDA
-24.01M
Float
N/A
Float - Current
N/A
Gross Income Margin
75.31
Revenue To Assets
-82.61
Shares Held By Institutions
3.02M
Shares Outstanding - Current
8.98M
Total Liabilities
30.3M
Total Volume MTD
N/A
Value
-1
Gain YTD
-18.482
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a blank check company, which was created with purpose to acquire, engage in a share exchange, share reconstruct, amalgate, and purchase all substantially all of the assets of, entering into contractual arrangements
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
6550 South Millrock Drive
Phone
+1 801 676-9695
Employees
85
Web
https://www.clene.com